Viz.ai
Software & Data
San Francisco, CA

Overall Rank: 41
Category: Software & Data
Category Rank: 11

Awards:

  • Top HealthTech Company of 2023

Profile

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,400+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, the Viz.ai Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.


Become a Premium Subscriber

Please purchase a premium subscription to continue reading this report.

Subscribe Now

Key Executives


  • Chris Mansi, MD, CEO and Co-Founder

  • David Kizner, General Counsel and Chief Privacy Officer

  • Dawn Sprague, Vice President of People

  • Gad Sakin, Chief Product Officer

  • Jayme Strauss, RN, MSN, MBA, SCRN, Chief Clinical Officer

  • Jieun Choe, Chief Marketing Officer

  • Julie Skaff, Chief Operating Officer

  • Kurt Blasena, Chief Revenue Officer

  • Steve Sweeny, Vice President, Business Development and Strategy


Board Members


  • Chris Mansi, MD, CEO and Co-Founder, Viz.ai

  • Mamoon Hamid, Partner at Kleiner Perkins

  • Mark Laret, President & CEO Emeritus at UCSF Health

  • Neil Shah, Partner at Greenoaks Capital

  • Rory O’Driscoll, Partner at Scale Venture Partners


Investors


  • CRV

  • Greenoaks

  • GV

  • Insight Partners

  • Innovation Endeavors

  • Kleiner Perkins

  • Scale Venture Partners

  • Sozo Ventures

  • Susa Ventures

  • Threshold

  • Tiger Global


News and Press Releases

Oct 2023: Viz.ai Honored by Goldman Sachs for Entrepreneurship (Read)


Sep 2023: Viz.ai Announces Expansion into Outpatient Ambulatory Centers to Accelerate Clinical Trial Recruitment in Heart Failure (Read)


Sep 2023: New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care Coordination (Read)


Sep 2023: Viz.ai to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Read)


Aug 2023: Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms (Read)


To know more about their latest news and press release, visit here.